Herbst Kinsky has advised the Biogena Group Invest AG on its capital increase to approximately four million shares.
Herbst Kinsky previously advised the group on the initial public offering of its shares and their listing on the Vienna Stock Exchange (as reported by CEE Legal Matters on December 15, 2020).
According to the firm, “the subscription period for the total of 1,995,000 new shares started on April 12, 2021 and ends on April 26, 2021, [and] both existing shareholders and new interested investors can already place orders for subscription.”
The Biogena Group is an Austrian developer and distributor of health and nutrition products. The company currently employs over 360 people and supplies to over 40 countries worldwide.
Herbst Kinsky's team was led by Attorney-at-Law Johannes Frank with the support of Associates Carmen Walser and Georg Durstberger.
